These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 26298331)

  • 1. Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis.
    Smith DJ; Combellick J; Jordan AE; Hagan H
    Int J Drug Policy; 2015 Oct; 26(10):911-21. PubMed ID: 26298331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973-2030.
    Meijerink H; White RA; Løvlie A; de Blasio BF; Dalgard O; Amundsen EJ; Melum E; Kløvstad H
    BMC Infect Dis; 2017 Aug; 17(1):541. PubMed ID: 28774261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis.
    Artenie A; Stone J; Fraser H; Stewart D; Arum C; Lim AG; McNaughton AL; Trickey A; Ward Z; Abramovitz D; Alary M; Astemborski J; Bruneau J; Clipman SJ; Coffin CS; Croxford S; DeBeck K; Emanuel E; Hayashi K; Hermez JG; Low-Beer D; Luhmann N; Macphail G; Maher L; Palmateer NE; Patel EU; Sacks-Davis R; Van Den Boom W; van Santen DK; Walker JG; Hickman M; Vickerman P;
    Lancet Gastroenterol Hepatol; 2023 Jun; 8(6):533-552. PubMed ID: 36996853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of fibrosis progression rates for chronic hepatitis C: a systematic review and meta-analysis update.
    Erman A; Krahn MD; Hansen T; Wong J; Bielecki JM; Feld JJ; Wong WWL; Grootendorst P; Thein HH
    BMJ Open; 2019 Nov; 9(11):e027491. PubMed ID: 31719068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias?
    Goodgame B; Shaheen NJ; Galanko J; El-Serag HB
    Am J Gastroenterol; 2003 Nov; 98(11):2535-42. PubMed ID: 14638360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015.
    Sun J; Althoff KN; Jing Y; Horberg MA; Buchacz K; Gill MJ; Justice AC; Rabkin CS; Goedert JJ; Sigel K; Cachay E; Park L; Lim JK; Kim HN; Lo Re V; Moore R; Sterling T; Peters MG; Achenbach CJ; Silverberg M; Thorne JE; Mayor AM; Crane HM; Kitahata MM; Klein M; Kirk GD;
    JAMA Netw Open; 2021 Feb; 4(2):e2037512. PubMed ID: 33595662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C Virus Disease Progression in People Who Inject Drugs: Protocol for a Systematic Review and Meta-Analysis.
    Combellick J; Smith DJ; Jordan AE; Hagan H
    JMIR Res Protoc; 2015 Jun; 4(2):e68. PubMed ID: 26054636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV.
    Limketkai BN; Mehta SH; Sutcliffe CG; Higgins YM; Torbenson MS; Brinkley SC; Moore RD; Thomas DL; Sulkowski MS
    JAMA; 2012 Jul; 308(4):370-8. PubMed ID: 22820790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes to the national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs between 2013 and 2016: a cross-sectional survey of 34 European countries.
    Maticic M; Zorman JV; Gregorcic S; Schatz E; Lazarus JV
    Harm Reduct J; 2019 May; 16(1):32. PubMed ID: 31072401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies.
    Duberg AS; Blach S; Falconer K; Kåberg M; Razavi H; Aleman S
    Scand J Gastroenterol; 2015 Feb; 50(2):233-44. PubMed ID: 25515032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001.
    Law MG; Dore GJ; Bath N; Thompson S; Crofts N; Dolan K; Giles W; Gow P; Kaldor J; Loveday S; Powell E; Spencer J; Wodak A
    Int J Epidemiol; 2003 Oct; 32(5):717-24. PubMed ID: 14559738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus (HCV) related liver fibrosis in people who inject drugs (PWID) at the Stockholm Needle Exchange - evaluated with liver elasticity.
    Kåberg M; Edgren E; Hammarberg A; Weiland O
    Scand J Gastroenterol; 2019 Mar; 54(3):319-327. PubMed ID: 30907178
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis C Reinfection in People Who Inject Drugs in Resource-Limited Countries: A Systematic Review and Analysis.
    Muller A; Vlahov D; Akiyama MJ; Kurth A
    Int J Environ Res Public Health; 2020 Jul; 17(14):. PubMed ID: 32659974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected Patients.
    Salmon-Ceron D; Nahon P; Layese R; Bourcier V; Sogni P; Bani-Sadr F; Audureau E; Merchadou L; Dabis F; Wittkop L; Roudot-Thoraval F;
    Hepatology; 2019 Sep; 70(3):939-954. PubMed ID: 30569448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C treatment as prevention of viral transmission and liver-related morbidity in persons who inject drugs.
    Cousien A; Tran VC; Deuffic-Burban S; Jauffret-Roustide M; Dhersin JS; Yazdanpanah Y
    Hepatology; 2016 Apr; 63(4):1090-101. PubMed ID: 26390137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: a longitudinal long-term cohort study.
    Kielland KB; Delaveris GJ; Rogde S; Eide TJ; Amundsen EJ; Dalgard O
    J Hepatol; 2014 Feb; 60(2):260-6. PubMed ID: 24096048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysis.
    Lockart I; Yeo MGH; Hajarizadeh B; Dore GJ; Danta M
    Hepatology; 2022 Jul; 76(1):139-154. PubMed ID: 35030279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes and Cirrhosis Are Risk Factors for Hepatocellular Carcinoma After Successful Treatment of Chronic Hepatitis C.
    Hedenstierna M; Nangarhari A; Weiland O; Aleman S
    Clin Infect Dis; 2016 Sep; 63(6):723-9. PubMed ID: 27282709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.
    Arum C; Fraser H; Artenie AA; Bivegete S; Trickey A; Alary M; Astemborski J; Iversen J; Lim AG; MacGregor L; Morris M; Ong JJ; Platt L; Sack-Davis R; van Santen DK; Solomon SS; Sypsa V; Valencia J; Van Den Boom W; Walker JG; Ward Z; Stone J; Vickerman P;
    Lancet Public Health; 2021 May; 6(5):e309-e323. PubMed ID: 33780656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.